HIV encephalitis is unusual in that neurologic damage occurs in the absence of significant infection of neuronal or glial cells.
Introduction
Neurologic deficits during life are increasingly being recognized as an important feature of infection with HIV. Further, -30% of terminally ill AIDS patients develop neurologic disease presumably caused by HIV infection of the brain (1) (2) (3) (4) . Neuropathologic study of these patients demonstrated microglial nodules and occasionally multinucleated giant cells. Sub-sequent immunohistochemical and in situ hybridization studies demonstrated HIV within these lesions, and this pathology has been named HIV encephalitis (HIV-E) (5) . While "viral burden" appears to be tightly associated with neuropathology (6) , such an association has not yet been made with clinical neurologic disease (dementia). After systemic HIV infection, viral invasion of the central nervous system (CNS)' occurs rapidly and frequently (7), however, the timing of significant CNS parenchymal infection is unknown. In unselected AIDS autopsies, there is a wide range in the severity ofHIV encephalitis (8) . Between 20 and 30% of AIDS patients develop severe HIV encephalitis in terminal stages of the disease (9-1 1 ).
A peculiar feature ofthis chronic encephalitis is that there is no evidence of significant neuronal or glial infection (12) (13) (14) . In the absence ofdirect lytic infection, it has been hypothesized that indirect effects ofHIV infected macrophages mediates neuronal damage ( 15) . In addition to being infected, CNS macrophages are clearly affected by HIV, showing morphologic transformation with abundant cytoplasm and processes, in addition to elevated expression of major histocompatibility complex class I and II molecules ( 16) . It is reasonable to hypothesize that such activated macrophages, and perhaps other cells, could release neurotoxic factors. Some of these factors (e.g., lipases and proteases) could mediate neurotoxicity nonspecifically while other factors (e.g., cytokines) mediate potent toxic effects by binding to cell surface receptors. Such factors proposed to mediate neurotoxicity in AIDS include IL-I fl, TNF-a, , gp120 (19) , and quinolinic acid (QUIN) ( 19) , as well as unidentified factors (20, 21 ) whose presence has been demonstrated only in vitro. Quantitation ofthese factors in the brain of HIV-infected patients has not been described. With respect to cytokines little is known about specific neuronal or glial surface receptors, except for IL-1 where hypothalamic receptors are well documented (22 [24] [25] [26] [27] [28] [29] .
Recently, we have examined the relationship between a variety of immune activation factors in the CSF and severity of HIV encephalitis. While significant intercorrelation between immune activation markers were found, no correlations were observed between these factors in the CSF and the severity of HIV encephalitis (23) . Because the CSF may not reflect local CNS tissue concentrations of these factors, we extracted specific CNS regions (frontal cortex, cerebral white matter, and basal ganglia) and directly evaluated the concentrations of immune activation factors and HIV in relationship to the severity of HIV encephalitis.
Methods
CNS material from 10 AIDS autopsies (Table I ) that had a postmortem time < 24 h were obtained. Based on previous screening for the severity of HIV encephalitis and availability of suitable frozen material, we selected three patients with low levels ofHIV and seven with high levels of HIV (see below for quantification and references). We excluded cases with opportunistic CNS infections or intermediate levels of HIV in the brain.
CSF was obtained through cervical spinal tap at the time ofautopsy and stored at -70°C until used for analysis. Routine tissue blocks from the following CNS regions were paraffin embedded for histopathologic diagnosis: frontal cortex, caudate nucleus, insular cortex, basal ganglia, thalamus, hypothalamus, hippocampus, superior cerebellum, midbrain, pons, medulla, and, when available, three levels of the spinal cord. To assess histopathology, routine hematoxylin and eosin staining was done on all of these blocks.
Immunocytochemistry for HIV envelope protein gp4l and scoring of HIV-E was performed as reported previously (9) . Sections Quinolinic acid was assayed in I00-Ml aliquots of 5% tissue homogemagnification of 20. All assessments were done blindly and indepennate by a modified gas chromatography/mass spectrometric method dently by two authors (C. A. Wiley and C. L. Achim). A composite (27, 29, 30) . gp4l score for each autopsy was derived by summing the individual Statistical analysis was performed using software (StatView II; Abascores of the three regions (ranges were 0-6).
cus Concepts, Inc., Berkeley, CA); correlation matrix for Pearson coefFrozen brain material was minced by using the commercially availficient and simple linear regression were determined using 95% confiable "Minibead beater" (Biospec Products, Inc., Bartlesville, OK). Alidence intervals. quots of 10% (wt/vol) homogenates from all regions of interest (cortical gray, cortical white, globus pallidus, and putamen) were obtained Results by homogenizing -100 mg of tissue in Tris buffer with 1-mm glass beads.
The concentrations of viral and immune activation factors in Equal aliquots of tissue homogenates from each region were used the CNS tissue extracts and previously reported CSF (23) (Fig. 1 a) .
Comparison of extract concentrations with CSF concentrations of p24, showed that only those cases with high tissue concentrations also had high CSF concentrations (Table II) . These correlations were statistically significant (Table III and Fig. 2) . While difficult to compare, the concentrations of p24 in the tissue extracts were substantially higher than those found in CSF (Table II) .
The highest concentrations of QUIN were also detected in severe HIV encephalitis (Table II) . In general, QUIN in tissue extracts correlated with its concentration in CSF (Fig. 2) . Commensurate with the neuropathology (gliosis, vacuolation, and microglial infiltration), regional analysis of QUIN concentrations showed higher levels in basal ganglia than in other brain regions (Fig. 1 b) , however, these differences were not statistically significant. Cytokine concentrations in the extracted tissues were uniformly low except for an occasional modest level of TNF-a (Table II) . Comparison with CSF concentrations ofthese same monokines showed no significant correlation. Despite strikingly high concentrations of IL-6 in the CSF ofmany autopsies, these levels were not reflected in the parenchyma.
Regional analysis of cytokines showed higher concentrations ofTNF-a in the basal ganglia (Fig. 1 c) . Regional analysis of cytokines in cases with minimal HIV encephalitis showed a gradient of TNF-a with highest concentration in basal ganglia (Fig. 1 c) . A similar analysis in cases with severe HIV encephalitis showed a uniform elevation in all three regions.
Discussion
Analysis of neurologic disease in AIDS is complicated by frequent opportunistic CNS infections. In the present study, we evaluated brains from autopsy cases where complete neuropathologic exam was possible. When initially described by Navia et al. in 1986 (2) those patients with AIDS dementia had neuropathology of microglial nodules some with multinucleated giant cells. Strangely, since that initial study there have been few reports carefully correlating the clinical symptomatology with neuropathologic finings. In part this may be because of the complexity of the task given the plethora of opportunistic infections (in particular cytomegalovirus [CMV] ) that can affect AIDS patients and make a one to one disease association difficult. Additionally, the definition of HIV encephalitis has evolved and the insensitive histopathological criteria of microglial nodules with multinucleated giant cells have been replaced with immunocytochemical and in situ hybridization detection of HIV (5) . The association of dementia with new sensitive and quantitative criteria needs to be studied methodically. Since opportunistic pathology is a potential source of immune activation in the brain of AIDS patients, we focused our attention on the neuropathologic changes associated with a significant HIV burden (i.e., HIV encephalitis), and define a pattern of immune activation specific to this condition.
Studies of a chronic viral encephalitis like that caused by HIV, require some quantitative appreciation for the severity of the encephalitis. As we have seen in previous studies (8) , HIV encephalitis is not an all or nothing event, but rather consists of a spectrum of viral burden. In our original definition of a scale for this spectrum, we used semiquantitative immunohistochemistry for HIV gp41. The present assessment of viral burden with HIV p24 antigen capture assay is in substantial agreement with the previously published gp41 assay. All subjects with high levels of HIV p24 in tissue extracts also had high CSF levels of p24 and high numbers of tissue macrophages that immunostained for HIV gp4 1. However, there were several cases with high numbers ofgp41 immunostained macrophages without elevated CSF or tissue p24 levels (Table II, cases A90-30 , A90-99, and A90-2 11). There could be multiple explanations for this disparity.
One explanation would be that HIV gp41 immunohistochemistry excessively labeled activated but not infected macrophages (false positive cells). We consider this possibility unlikely, since immunostains of other neurologic diseases (e.g., stroke, progressive multifocal leukoencephalopathy) (9) with abundant activated macrophages, do not show false positive staining. A second explanation is that HIV p24 antigen is less stable during the time between death and autopsy and therefore absence of detection is a false negative. This explanation also does not appear likely because there was no association between the postmortem interval and the antigen capture results. However, it has been our and others experience (31 ) , that HIV p24 antigen is more difficult to preserve than gp4 1; e.g., immunohistochemistry for p24 requires frozen rather than paraffin sections. A third explanation is that those observations of a disjunction between gp4 1 and p24 concentrations are not artifact, but rather are evidence of differential transcription or translation of HIV in the CNS. Envelope proteins (e.g., gp4 1) are translated mostly from doubly-spliced mRNA, while gag proteins (e.g., p24) are translated from unspliced mRNA. Splicing is under exquisitely fine control of transcriptionally active regulator proteins like Tat and Rev. It would be reasonable to hypothesize that within CNS macrophages, there is preferential production of HIV envelope proteins leading to greater sensitivity of detecting infected cells with envelope markers. We favor this interpretation despite the fact that it is counter to previously published data (32) , suggesting that in vitro macrophages produce less envelope protein.
HIV replication in CNS macrophages of AIDS patients would be expected to perturb the functions of these cells, including production of monokines (which could also affect the function of noninfected cells). As others have done, we chose antigen capture assays to study cytokines within the CNS in part because of the ease of quantitation. An Previous autopsies studies have suggested that HIV infection begins in the deep gray matter and later spreads to the neocortex. Elevated TNF-a levels appear to mimic this progression, being high in deep gray matter in "early" HIV encephalitis (low gp4 1 expression) and more equally elevated in cortical gray and white matter in severe HIV encephalitis (Fig. 1 c) . The strong correlation between gp4 1 scores and TNF-a in the cortical gray matter may reflect the late arrival of HIV to the neocortex with late stimulation of TNF-a production.
Striking differences were found between CSF and tissue concentrations of the various compounds. There was no correlation between CSF and tissue measurements ofIL-6; however, it is interesting to note that IL-6 was very high in the CSF and low in the parenchyma, while the opposite was the case with p24 measurements. This would suggest that while CSF can reflect tissue findings, the CSF and CNS parenchyma are clearly very different compartments of the body. Changes in one compartment may be completely independent of the other. There was a good correlation between CSF and tissue measurements of p24. This could imply good diffusion or mix-ing of between these two compartments or alternatively systemic conditions permitting changes in the tissue compartment equally affect the CSF.
Brain parenchyma QUIN levels were markedly increased in the HIV-infected patients, particularly in the basal ganglia. Previously we have observed striking regional differences in CNS QUIN levels in conditions of focal inflammatory disease with significantly more QUIN in inflamed regions than in noninflamed ones (27, 29) . These studies suggest that the transfer of QUIN from tissue into CSF occurs readily, the transfer of QUIN from the CSF into the brain parenchyma is slight. In the present study, the two cases where CSF QUIN levels were markedly increased without substantial elevations in tissue QUIN levels ( Fig. 2 b, squares) were the patients with meningitis without signs of HIV encephalitis. It is likely that QUIN has been synthesized within the meninges rather than the brain parenchyma; when these two cases were excluded from the regression analysis, the correlation between CNS and CSF QUIN concentration was 0.88. The elevated CSF QUIN levels probably reflect locally synthesized QUIN in inflamed meninges rather than the brain parenchyma. HIV-infected patients with aseptic meningitis have substantial elevations in CSF QUIN but may have no or minimal symptoms of the AIDS dementia complex (26) . Such lack of CNS dysfunction, in the face of elevated CSF levels of the neurotoxin, may therefore be explained by a lack of QUIN increases in the brain parenchyma. From a functional perspective, the source of QUIN is immaterial to the fact that QUIN levels are increased within the brain parenchyma of all patients compared to normal values.
Recently, we have reported that human macrophages in vitro stimulated with IFN--y produce large amounts of QUIN, that is attributable to induction of the synthetic enzymes for QUIN, including indoleamine-2,3-dioxygenase (19, 27, 34) . Indeed, increases in CNS QUIN levels and indoleamine-2,3-dioxygenase induction occur across a broad spectrum ofinflammatory neurologic disease and brain injury, independent of HIV infection, and the increases in CNS QUIN are correlated with markers of macrophage and immune activation (neopterin, 32-microglobulin, IgG and pleocytosis, if present) (23, 28, 35) . While human post mortem studies of IDO are difficult because ofenzyme lability, the present results tend to show that QUIN levels are related to the severity of inflammatory responses within the CNS. It is of note that the actual molar QUIN concentrations in the brain parenchyma that were achieved (up to 13,580 vs 80 nmol/kg in noninfected controls) exceeded the nanomolar/low micromolar levels already demonstrated to be neurotoxic to certain neuronal populations including organotypic corticostriatal neurons (20, 36) . Interestingly, parenchymal levels of QUIN were highest in the basal ganglia, a region rich in the NMDA receptors that mediate the neurologic effects of QUIN (37). Because motor deficits and inflammatory neuropathologic lesions in these areas are characteristics of HIV encephalitis, it would be reasonable to hypothesize that QUIN may act as a pathological agonist of this receptor to mediate neurologic damage in these regions.
